Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

LabelMD: FDA Drug Label Lookup

LabelMD: FDA Drug Label Lookup

By CAMILE ALVES ANCINES LTDA

LabelMD is a medical reference tool for iOS that provides direct access to official FDA drug labels, interaction checking, and NDC barcode scanning.

The App DNA

What makes this app unique?

Medical professionals require a fast, reliable, and bias-free source for prescribing information that functions without the dependency of constant internet connectivity.

For Pharmacists, nurses, physicians, and medical students requiring rapid, accurate access to official FDA drug data.

What does it look like?

Key features

Drug Interaction Checkeredge

Screens up to 10 drugs simultaneously for documented interactions using FDA-approved labeling.

NDC Barcode Scanneredge

Uses camera to read NDC barcodes on drug packaging for instant label retrieval.

Offline Cachestandard

Stores drug labels locally for access without internet connectivity.

How much does it cost?

freemiumFree tier with 3 searches per dayBasic tier at $1.99/monthPremium tier at $4.99/month

The freemium model gates high-value clinical tools like interaction checking and barcode scanning behind a $4.99/month subscription.

Velocity

Maintenance developmentUX improvementsperformanceShow more...

The app maintains a maintenance-level cadence, with only one release shipped in the last 59 days. Development is focused on refining existing functionality, specifically improving interaction detection and clarifying the scope of FDA label data. The latest release provides offline access for recent searches and enhances the interaction checker's accuracy. There is no evidence of a high-frequency update cycle or live-service operations.

See all version history

Who built it?

CAMILE ALVES ANCINES LTDA

2 apps tracked · Medical

GrowthMD: Pediatric ChartsGrowthMD: Pediatric Charts
Explore the full publisher profile

User Sentiment

What do users think recently?

How are ratings & reviews evolving?

App Store
0.00 · 0

Not enough recent reviews to extract reliable themes yet.

Read the full review analysis

Competition

Competitive landscape for LabelMD: FDA Drug Label Lookup

How's the Medical market?

LabelMD occupies a niche in the medical reference space by leveraging the openFDA API for official, unedited data. The lack of recent store ratings suggests a low-velocity acquisition funnel, signaling that the app currently relies on organic discovery rather than chart-driven growth.

Read the market outlook

The rivals identified

Unlock the deeper market read.

Access the full report for free

The Analyst's Read

Key takeaways for LabelMD: FDA Drug Label Lookup

Where is it heading?

The medical reference market is consolidating around tools that offer integrated clinical decision support. LabelMD remains advantaged by its direct FDA data source, but it must increase its update frequency to remain relevant against competitors that offer more frequent clinical content refreshes.

  • The 8-week update cadence indicates a maintenance-focused posture rather than aggressive feature expansion, limiting growth potential in the competitive medical reference category.
  • Free offline access for recent searches reduces the barrier to entry for medical students, which may improve long-term retention as they transition to clinical practice.

The SWOT

Core Strengths
  • Direct openFDA API integration ensures official, unedited prescribing data
  • Offline cache for recent searches removes connectivity dependencies in clinical settings
  • NDC barcode scanner enables rapid lookup during medication administration
Critical Frictions 2 weaknesses inside
Growth Levers
  • Institutional licensing could bypass individual subscription friction in hospital networks
  • Expansion of offline cache capacity beyond 20 items would increase value for rural clinical practitioners
Market Threats 2 threats identified

Next best moves

1 Invest

Expand offline cache capacity because clinical users report connectivity gaps in hospital basements → increase daily active usage

The counter-intuitive read

LabelMD's lack of editorial rewriting is its primary asset…

Read the full take

Since the last report: LabelMD has pivoted its strategic focus from maintenance-only updates to institutional growth and offline utility expansion. The roadmap now prioritizes increasing offline cache capacity to address clinical connectivity gaps over the previous focus on interaction checker performance audits.

Bottom line

LabelMD's reliance on the openFDA API provides a high-trust reference tool, but the maintenance-mode cadence risks stagnation against competitors with more frequent clinical updates. Expanding the offline cache would solidify its utility in resource-constrained environments.

Unlock 2 critical frictions, 2 market threats and the analyst’s take.

Access the full report for free

Sources

  1. [1] App Store listing

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by LabelMD: FDA Drug Label Lookup, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

LabelMD has pivoted its strategic focus from maintenance-only updates to institutional growth and offline utility expansion. The roadmap now prioritizes increasing offline cache capacity to address clinical connectivity gaps over the previous focus on interaction checker performance audits.

added

Institutional Licensing Opportunity

added

API Dependency Threat

added

Barcode Scanner Strength

Cite this report

Marlvel.ai. “LabelMD: FDA Drug Label Lookup Intelligence Report.” Updated Sep 5, 2026. https://marlvel.ai/apps/labelmd-fda-drug-label-lookup

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0